School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.
School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Am J Clin Nutr. 2023 Mar;117(3):564-575. doi: 10.1016/j.ajcnut.2023.01.005. Epub 2023 Jan 13.
Although a number of health outcomes such as CVDs, metabolic-related outcomes, neurological disorders, pregnancy outcomes, and cancers have been identified in relation to B vitamins, evidence is of uneven quality and volume, and there is uncertainty about putative causal relationships.
To explore the effects of B vitamins and homocysteine on a wide range of health outcomes based on a large biorepository linking biological samples and electronic medical records.
First, we performed a phenome-wide association study (PheWAS) to investigate the associations of genetically predicted plasma concentrations (genetic component of the circulating concentrations) of folate, vitamin B6, vitamin B12, and their metabolite homocysteine with a wide range of disease outcomes (including both prevalent and incident events) among 385,917 individuals in the UK Biobank. Second, 2-sample Mendelian randomization (MR) analysis was used to replicate any observed associations and detect causality. We considered MR P <0.05 as significant for replication. Third, dose-response, mediation, and bioinformatics analyses were carried out to examine any nonlinear trends and to disentangle the underlying mediating biological mechanisms for the identified associations.
In total, 1117 phenotypes were tested in each PheWAS analysis. After multiple corrections, 32 phenotypic associations of B vitamins and homocysteine were identified. Two-sample MR analysis supported that 3 of them were causal, including associations of higher plasma vitamin B6 with lower risk of calculus of kidney (OR: 0.64; 95% CI: 0.42, 0.97; P = 0.033), higher homocysteine concentration with higher risk of hypercholesterolemia (OR: 1.28, 95% CI: 1.04, 1.56; P = 0.018), and chronic kidney disease (OR: 1.32, 95% CI: 1.06, 1.63; P = 0.012). Significant nonlinear dose-response relationships were observed for the associations of folate with anemia, vitamin B12 with vitamin B-complex deficiencies, anemia and cholelithiasis, and homocysteine with cerebrovascular disease.
This study provides strong evidence for the associations of B vitamins and homocysteine with endocrine/metabolic and genitourinary disorders.
尽管已经确定了多种健康结果与 B 族维生素有关,如心血管疾病、代谢相关结果、神经紊乱、妊娠结果和癌症,但证据的质量和数量参差不齐,并且对于假定的因果关系存在不确定性。
基于一个将生物样本与电子病历联系起来的大型生物库,探索 B 族维生素和同型半胱氨酸对广泛健康结果的影响。
首先,我们进行了全基因组关联研究(PheWAS),以调查在英国生物库中 385917 名个体中,遗传预测的血浆浓度(循环浓度的遗传成分)与广泛的疾病结果(包括现患和新发事件)之间的关联。其次,采用双样本 Mendelian 随机化(MR)分析来复制任何观察到的关联并检测因果关系。我们认为 MR P <0.05 具有显著意义。第三,进行剂量-反应、中介和生物信息学分析,以检查任何非线性趋势,并阐明所确定关联的潜在介导生物学机制。
在每个 PheWAS 分析中总共测试了 1117 种表型。经过多次校正,确定了 B 族维生素和同型半胱氨酸的 32 种表型关联。双样本 MR 分析支持其中 3 种具有因果关系,包括较高的血浆维生素 B6 与较低的肾结石风险相关(OR:0.64;95%CI:0.42,0.97;P = 0.033),较高的同型半胱氨酸浓度与较高的高胆固醇血症风险相关(OR:1.28,95%CI:1.04,1.56;P = 0.018),以及慢性肾脏病(OR:1.32,95%CI:1.06,1.63;P = 0.012)。还观察到叶酸与贫血、维生素 B12 与维生素 B 复合物缺乏、贫血和胆石症以及同型半胱氨酸与脑血管疾病之间的关联存在显著的非线性剂量-反应关系。
本研究为 B 族维生素和同型半胱氨酸与内分泌/代谢和泌尿生殖系统疾病的关联提供了强有力的证据。